{"id":20019,"date":"2026-02-26T16:33:54","date_gmt":"2026-02-26T16:33:54","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/20019\/"},"modified":"2026-02-26T16:33:54","modified_gmt":"2026-02-26T16:33:54","slug":"roche-gets-ce-mark-for-cgm-mysugr-integration","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/20019\/","title":{"rendered":"Roche gets CE mark for CGM, Mysugr integration"},"content":{"rendered":"<p>Roche Holdings AG received CE mark approval for the integration of its AI-enabled continuous glucose monitoring system, Accu-Chek Smartguide, with the Mysugr diabetes management app. The integrated solution, which combines predictive CGM technology with therapy data in one place, will simplify the daily decision-making for users managing their diabetes.<\/p>\n<p><a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/85-medical-technology\" rel=\"nofollow noopener\" target=\"_blank\">Medical technology<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/402-regulatory\" rel=\"nofollow noopener\" target=\"_blank\">Regulatory<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/344-continuous-glucose-monitor-cgm\" rel=\"nofollow noopener\" target=\"_blank\">Continuous glucose monitor (CGM)<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/243-diabetes\" rel=\"nofollow noopener\" target=\"_blank\">Diabetes<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/396-europe\" rel=\"nofollow noopener\" target=\"_blank\">Europe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Roche Holdings AG received CE mark approval for the integration of its AI-enabled continuous glucose monitoring system, Accu-Chek&hellip;\n","protected":false},"author":2,"featured_media":20020,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[124],"tags":[11550,4176,13112,9897,13110,7250,197,8050,4180,134,473,13111],"class_list":{"0":"post-20019","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-roche","8":"tag-abbott-laboratories","9":"tag-bioworld-medtech","10":"tag-continuous-glucose-monitor-cgm","11":"tag-continuous-glucose-monitoring","12":"tag-dexcom-inc","13":"tag-diabetes","14":"tag-europe","15":"tag-medtech","16":"tag-regulatory","17":"tag-roche","18":"tag-roche-holding-ag","19":"tag-sensors"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/20019","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=20019"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/20019\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/20020"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=20019"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=20019"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=20019"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}